Sparrow Pharmaceuticals, Inc. announced it raised $1.08 Million in an initial filing from an offering of $50.8 Million
Jan 13, 2021•over 4 years ago
Amount Raised
$1.08 Million
Round Type
seed
PortlandHealth Care
Company Information
Company
Sparrow Pharmaceuticals
Location
1050 Southwest 6th Street, Suite 1100
Portland, Oregon, United States
About
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical development.
Portland